An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome
2024 · Human Genetics and Genomics Advances · 0 citations
https://doi.org/10.1016/j.xhgg.2024.100393
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
222
Citations
2
h-index
2
i10-index
MICHAEL SNAPE is an academic researcher from Kennedy Krieger Institute. The author has contributed to research in topics: Autism Spectrum Disorder Research & Attention Deficit Hyperactivity Disorder & Neurological disorders and treatments. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat